VTYX
Income statement / Annual
Last year (2024), Ventyx Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Ventyx Biosciences, Inc.'s net income was -$135.12 M.
See Ventyx Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$941.00 K
|
$470.00 K
|
$30.00 K
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$941.00 K
|
-$470.00 K
|
-$30.00 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$117.00 M
|
$175.77 M
|
$87.74 M
|
$58.48 M
|
$6.37 M
|
$3.55 M
|
| General & Administrative Expenses |
$31.45 M
|
$32.23 M
|
$25.40 M
|
$8.67 M
|
$684.00 K
|
$628.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$31.45 M
|
$32.23 M
|
$25.40 M
|
$8.67 M
|
$684.00 K
|
$628.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
$41.00 K
|
-$5.45 M
|
-$1.00 K
|
-$1.00 K
|
| Operating Expenses |
$148.45 M
|
$207.99 M
|
$113.14 M
|
$67.15 M
|
$7.05 M
|
$4.18 M
|
| Cost And Expenses |
$0.00
|
$207.99 M
|
$113.14 M
|
$67.15 M
|
$7.05 M
|
$4.18 M
|
| Interest Income |
$0.00
|
$15.07 M
|
$4.67 M
|
$78.00 K
|
$358.00
|
$146.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$99.00 K
|
$358.00 K
|
$146.00 K
|
| Depreciation & Amortization |
$1.35 M
|
$158.00 K
|
$470.00 K
|
$30.00 K
|
$7.05 M
|
$4.18 M
|
| EBITDA |
-$133.77 M |
-$207.84 M |
-$107.96 M |
-$67.12 M |
$0.00 |
-$1.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$13.33 M
|
$15.03 M
|
$4.71 M
|
-$16.60 M
|
-$21.12 M
|
-$147.00 K
|
| Income Before Tax |
-$135.12 M
|
-$192.96 M
|
-$108.43 M
|
-$83.75 M
|
-$28.17 M
|
-$4.33 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
-$470.00 K
|
-$5.38 M
|
$358.00 K
|
$146.00 K
|
| Net Income |
-$135.12 M
|
-$192.96 M
|
-$107.96 M
|
-$78.37 M
|
-$28.53 M
|
-$4.47 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.97 |
-3.3 |
-2.06 |
-1.55 |
-0.57 |
-0.0889 |
| EPS Diluted |
-1.97 |
-3.3 |
-2.06 |
-1.55 |
-0.57 |
-0.0889 |
| Weighted Average Shares Out |
$68.48 M
|
$58.54 M
|
$52.47 M
|
$50.41 M
|
$50.30 M
|
$50.30 M
|
| Weighted Average Shares Out Diluted |
$68.48 M
|
$58.54 M
|
$52.47 M
|
$50.41 M
|
$50.30 M
|
$50.30 M
|
| Link |
|
|
|
|
|
|
